- Home
- BH vs HROW Comparison
BH vs HROW Comparison
Compare BH & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BH
- HROW
- Stock Information
- Founded
- BH 1934
- HROW 1998
- Country
- BH United States
- HROW United States
- Employees
- BH N/A
- HROW N/A
- Industry
- BH Restaurants
- HROW Biotechnology: Pharmaceutical Preparations
- Sector
- BH Consumer Discretionary
- HROW Health Care
- Exchange
- BH Nasdaq
- HROW Nasdaq
- Market Cap
- BH 527.5M
- HROW 1.6B
- IPO Year
- BH N/A
- HROW N/A
- Fundamental
- Price
- BH $172.00
- HROW $56.41
- Analyst Decision
- BH
- HROW Strong Buy
- Analyst Count
- BH 0
- HROW 4
- Target Price
- BH N/A
- HROW $55.00
- AVG Volume (30 Days)
- BH 2.2K
- HROW 474.8K
- Earning Date
- BH 11-01-2024
- HROW 11-11-2024
- Dividend Yield
- BH N/A
- HROW N/A
- EPS Growth
- BH N/A
- HROW N/A
- EPS
- BH N/A
- HROW N/A
- Revenue
- BH $362,194,000.00
- HROW $154,146,000.00
- Revenue This Year
- BH N/A
- HROW $52.51
- Revenue Next Year
- BH N/A
- HROW $41.21
- P/E Ratio
- BH N/A
- HROW N/A
- Revenue Growth
- BH N/A
- HROW 50.06
- 52 Week Low
- BH $137.01
- HROW $7.60
- 52 Week High
- BH $219.00
- HROW $57.20
- Technical
- Relative Strength Index (RSI)
- BH 51.33
- HROW 78.98
- Support Level
- BH $168.89
- HROW $48.53
- Resistance Level
- BH $173.60
- HROW $52.45
- Average True Range (ATR)
- BH 3.25
- HROW 2.48
- MACD
- BH 0.56
- HROW 0.44
- Stochastic Oscillator
- BH 82.18
- HROW 94.48
About BH Biglari Holdings Inc. Class B
Biglari Holdings Inc is a holding company that owns subsidiaries in a range of businesses. The company's reportable segments include Restaurant Operations, Insurance Operations, Oil and Gas Operations, and Maxim. The majority of revenue is derived from the Restaurant Operations segment. The Restaurant Operations segment includes Steak n Shake and Western Sizzlin Restaurant businesses.
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans.